Drug history and cigarette smoking data for the four disc appearance groups
| Focal ischaemic (FI) | Myopic glaucomatous (MG) | Senile sclerotic (SS) | Generalised cup enlargement (GE) | p Value | |
|---|---|---|---|---|---|
| Number | 38 | 37 | 24 | 24 | |
| Vasoactive eye medication (n (%)) | 24 (63.2) | 20 (54.1) | 14 (58.3) | 14 (58.3) | ns |
| Vasoactive oral medication (n (%)) | 6 (15.8) | 4 (10.8) | 12 (50.0) | 5 (20.8) | 0.0006 |
| Aspirin (n (%)) | 6 (15.8) | 5 (13.5) | 6 (25.0) | 1 (4.2) | ns |
| Ex/smoker (n (%)) | 18 (47.3) | 12 (32.4) | 11 (45.8) | 15 (62.5) | ns |
| Smoking years (mean (SD)) | 8.5 (11.8) | 4.5 (9.2) | 12.2 (15.5) | 14.6 (16.7) | 0.02 |
| Cigarettes/day (mean (SD)) | 3.9 (7.4) | 5.3 (6.7) | 6.4 (10.3) | 6.3 (8.2) | ns |
| Age adjusted number of cigarettes smoked (mean (SD)) | 1014 (1633) | 786 (1617) | 684 (1290) | 713 (1460) | ns |
ns = no significant differences.
↵Pearson’s χ2 or Fisher’s exact test for categorical data; analysis of variance (ANOVA) for continuous data with Duncan’s correction for multiple comparisons (p<0.05).
↵Patients in the senile sclerotic group were taking more vasoactive systemic medications in comparison with the other groups.
↵Patients in the myopic glaucoma group had smoked for less years in comparison with those in either the senile sclerotic or generalised cup enlargement groups.